Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil K Joshi

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Annual Review of Pharmacology and Toxicology|September 22, 2023
Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision MedicineSunil K Joshi, Paul Piehowski, Tao Liu, et al.
Blood|April 22, 2020
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasmsSunil K Joshi, Kristin Qian, William H Bisson, et al.
Elife|February 6, 2019
FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cellsNathalie Javidi-Sharifi, Jacqueline Martinez, Isabel English, et al.
Journal of Cardiovascular Pharmacology|September 1, 2015
Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary AtherosclerosisFu Sang Luk, Roy Y Kim, Kang Li, et al.
Cancer Discovery|May 4, 2019
The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML CellsTamilla Nechiporuk, Stephen E Kurtz, Olga Nikolova, et al.
Haematologica|February 13, 2025
Oncogenic <i>NTRK3</i> mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemiaSunil K Joshi, Ariane Huang, Janét Pittsenbarger, et al.
Pathogens & Immunity|September 23, 2017
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected IndividualsLeslie R Cockerham, Steven A Yukl, Kara Harvill, et al.
Cell Reports. Medicine|January 17, 2024
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemiaJames C Pino, Camilo Posso, Sunil K Joshi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2018
LSD1 activates a lethal prostate cancer gene network independently of its demethylase functionArchana Sehrawat, Lina Gao, Yuliang Wang, et al.
Cancer Cell|June 25, 2021
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistanceSunil K Joshi, Tamilla Nechiporuk, Daniel Bottomly, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Annual Review of Pharmacology and Toxicology|September 22, 2023
Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision MedicineSunil K Joshi, Paul Piehowski, Tao Liu, et al.
Blood|April 22, 2020
Discovery and characterization of targetable NTRK point mutations in hematologic neoplasmsSunil K Joshi, Kristin Qian, William H Bisson, et al.
Elife|February 6, 2019
FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cellsNathalie Javidi-Sharifi, Jacqueline Martinez, Isabel English, et al.
Journal of Cardiovascular Pharmacology|September 1, 2015
Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary AtherosclerosisFu Sang Luk, Roy Y Kim, Kang Li, et al.
Cancer Discovery|May 4, 2019
The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML CellsTamilla Nechiporuk, Stephen E Kurtz, Olga Nikolova, et al.
Haematologica|February 13, 2025
Oncogenic <i>NTRK3</i> mutations exhibit differential sensitivity to tropomyosin receptor kinase inhibitors in patients with acute myeloid leukemiaSunil K Joshi, Ariane Huang, Janét Pittsenbarger, et al.
Pathogens & Immunity|September 23, 2017
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected IndividualsLeslie R Cockerham, Steven A Yukl, Kara Harvill, et al.
Cell Reports. Medicine|January 17, 2024
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemiaJames C Pino, Camilo Posso, Sunil K Joshi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2018
LSD1 activates a lethal prostate cancer gene network independently of its demethylase functionArchana Sehrawat, Lina Gao, Yuliang Wang, et al.
Cancer Cell|June 25, 2021
The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistanceSunil K Joshi, Tamilla Nechiporuk, Daniel Bottomly, et al.
Pageof 6